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Genetically-determined regional differences in the GABA-ergic make-up of the brain exist in two lines of Wistar rats viz.: 
apomorphine-susceptible (APO-SUS) and apomorphine-unsusceptible (APO-UNSUS) Wistar rats. Propofol is a G A BA - 
mimetic general anesthetic. This study compared the responses to propofol in APO-SUS and A PO -U N SU S rats. Propofol 
induced a higher incidence of involuntary muscular contractions and oral movements, but a lower incidence of grooming, 
in APO-SUS rats than in APO-UNSUS rats. Reflex inhibition and narcosis, being defined as the behavior marked by both 
full absence of purposeful movements and by complete loss of righting reflexes, after propofol did not differ between the 
two lines. APO-SUS rats had less variation of the heart rates and greater variations of diastolic arterial pressures in response 
to electrical stimulation than the APO-UNSUS rats, and these variations were reduced by increasing doses of propofol. 
Arterial pressures in APO-SUS rats were higher than in APO-UNSUS rats. Propofol caused a biphasic change in intra- 
arterial pressures and had the greatest effect in APO-SUS rats. Differences in cerebral G A B A  transmission, especially in 
the striato-nigro-collicular pathway, did not give rise to differences in the effect of propofol on narcosis and hindlimb 
withdrawal reflex. In contrast, these differences in G A B A  transmission were accompanied by line-specific differences in 
effect of propofol on certain behavioral and cardiovascular parameters. © 1997 Elsevier Science Inc.
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GENERAL anesthesia involves narcosis, reflex suppression 
and relaxation (19). GABA neurotransmission plays a role in 
anesthetic-induced narcosis (18,29,30,31*38,39) and associated 
changes in cognition (vigilance), behavior, motor perfor­
mance, reflexes and cardiovascular regulation (7,25,27,39). Re­
cently, it was found that inbred differences in response to 
diazepam, a drug that can indirectly enhance GABA transmis­
sion in the brain, are associated with differences in volatile 
anesthetic requirements (28). This suggests that the response 
to anesthetics which affect the GABA transmission, may vary 
according to genetically determined differences in the GABA- 
ergic make-up of the brain. In the present study, we investi­
gated to what extent the effects of propofol, an anesthetic 
that among others enhances the GABA function (1,9,21,32),
vary in rats which have determined differences among others 
in the GABA-ergic make-up of the brain (10,11,12,33).
The apomorphine-susceptible (APO-SUS) and the apo­
morphine-unsusceptible (APO-UNSUS) Wistar rat lines were 
chosen. These rat lines are marked by a mirror image of the 
functional activity of G A BA  transmission in the striato-nigro- 
collicular pathway: APO-SUS rats have a relatively low activ­
ity at the level of the substantia nigra, pars reticulata and a 
relatively high activity at the level of the deeper layers of 
the colliculus superior. APO-UNSUS rats show precisely the 
opposite activity in these brain regions (10). Propofol [2,6- 
di-isopropyl phenol (Diprivan®)] was chosen as the anesthetic 
because at least part of its actions is due to its ability to 
enhance the function of the G AB A A/ionophore receptor com-
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plex (1,9,21,32), and it is noteworthy that propofol shares the 
ability to take effect via this site with various chemically dis­
tinct classes of general anesthetics agents (38). An additional 
criterion for selecting propofol is its short duration of effect, 
especially as a pilot study showed that this feature allowed 
for the assessment of dose response curves in individual rats. 
Four types of the main responses to propofol, i.e. narcosis, 
inhibition of reflexes, drug-evoked behavioral signs, and car­
diovascular changes, were studied (3,4,6,8,24,26,34).
METHOD
Animals
Subjects were nine female apomorphine-susceptible (APO- 
SUS; body weight 255 ± 2 g) and nine female apomorphine- 
unsusceptible (APO-UNSUS; body weight 225 ± 6 g) Wistar 
rats bred and reared in the Central Animal Laboratory, Uni­
versity of Nijmegen, the Netherlands. Rats belonging to the 
13th generation of the APO-SUS and APO-UNSUS lines were 
used. Parents of the APO-SUS and APO-UNSUS lines, which 
had produced 100% offspring with apomorphine-induced 
gnawing scores characteristic for their line, were identified. 
Only naive female rats, belonging to the second litter of these 
parents, were used in the present study. Further procedural 
details on animal breeding, maintenance and selection of these 
rat lines have been described elsewhere in detail (10). The 
rats were housed 2-3 animals per Macrolon cage (36 X 24 x  
25 cm) and received manufactured food and tap water ad lib. 
They were kept at a 12 h light/dark cycle with white lights on 
at 0600 a.m ., and the environmental temperature was 20°C 
(range 18-22°C).
Drug
Propofol (2,6-di-isopropyl phenol (Diprivan®)) dissolved 
in its vehicle (aqueous emulsion containing 10% w/v Soya 
bean oil, 1.2% w/v egg phosphatide and 2.25% w/v glycerol) 
was intravenously (IV) given in a volume of 1 ml.kg"1. The 
doses of 20 or 40 m g .k g '1 were delivered in a volume of 2 
and 4 ml,kg"\ respectively.
PREPARATIONS
Study on Narcosis and Drug-Induced Behavior
A cannula (Insyte® 24 G, Becton Dickinson, USA) was 
introduced into a tail vein and connected via an extension set 
with T (venisystems®, ABBOTT, Belgium) to a 1 ml syringe 
(Monoject Tuberculin, Sherwood Medical, Crawley, Sussex, 
UK). Once secured, the injection of propofol was given, and 
the rat was placed on a flat, wooden table (60 x  80 X 90 cm). 
The behavior was analyzed until the rat was fully recovered 
from the drugs effect (see below).
Study on Withdrawal Reflex and Cardiovascular Variables
The rat was anesthetized with an intraperitoneal (IP) injec­
tion of urethane (1.2 g.kg“ 1) to allow cannulation of the right 
internal jugular vein. When the jugular vein was cannulated, 
aliquots urethane were injected intravenously to a total of 0.2 
g.kg~\ and the trachea and right carotid artery were cannu­
lated. This total dose of urethane (1.4 g.kg-1) delivered within 
the first half h maintained anesthesia during the experiments. 
After cannulation, the rat was placed on the experimentation 
table. The trachea cannula was used for artificial normo venti­
lation. The cannula in the carotid artery was connected to a
pressure transducer (Viggo-Spectramed, BOC, USA) which 
provided a measure for the intra-arterial (IA) pressures. The 
heart rate was derived from the arterial pressure signal (heart 
rate counter AT-601G, Nihon Kohden Corp., Japan). The 
right hind paw was mounted in a shoe which contained two 
electrodes allowing transcutaneous bipolar stimulation (Grass 
stimulator S l l ,  with stimulus isolation unit SIU5A, and con­
stant current unit CCU1A). Stimulation parameters were set 
to 4 ms pulse duration, 7.5 mA stimulus strength, 100 Hz pulse 
frequency, in a train of 500 ms duration, and a repetition rate 
of 12.5 mHz (0.75 min~l) for the trains (i.e. every 80 s a 
stimulus). The hind paw was also connected to a force-dis- 
placement transducer (TB-611T, Nihon Kohden Corp., Ja­
pan), which allowed the measurement of the withdrawal force 
response to the electrical stimulus. Details on the method have 
been described elsewhere (13).
EXPERIMENTAL DESIGN AND MEASURES
Study on Narcosis and Drug-Induced Behavior
Different doses of propofol had been tested in a pilot study 
using outbred Wistar rats. Attention was paid to (a) occur­
rence of narcosis (criterion for start of narcosis is abolishment 
of purposeful movements, at which moment the ability to 
regain upright position is lost. The endpoint of effect was 
the moment of head lift), (b) absence of toxic effects (e.g. 
cardiovascular collapse), (c) behavioral symptoms preceding 
and/or following narcosis, (d) presence/absence of tolerance, 
and (e) that propofoPs vehicle was without effect.
On the basis of the outcome of that study, we selected the 
solvent of propofol (see Drug) and chose the following dosing 
schemes, Propofol was administered in the doses of 4, 10 and 
20 mg.kg~l, IV. Each dose was injected several times per trial: 
n = 4/4 mg.kg“1, IV \n  = 3/10 mg. kg“1, IV; n = 2/20 mg.kg"1, 
IV, The interinjection interval was determined per individual 
and terminated as soon as the rat lifted its head. The total 
number of trials was 3 per animal; with an interval of I week 
between trials; there were 9 rats in each group. Each class 
of rat (APO-SUS and APO-UNSUS) was divided in three 
subgroups. The iirst group received 4 consecutive injections 
of 4 nig.kg"'1 in week 1,3 consecutive injections of 10 mg.kg“"1 
in week 2, and 2 consecutive injections of 20 mg.kg“1 in week 
3. The second and third groups received the same treatments, 
but in another order: 20 mg.kg"1, 10 mg.kg~‘ and 4 mg.kg"1 
(second group), and 10 mg.kg“1, 20 mg.kg“ 1 and 4 mg.kg“1 
(third group). Since the pilot study had shown that the effect 
of the first injection often differed from that of the consecutive 
injections, these effects were separately analyzed.
The pilot study was also used for selecting the behavioral 
items to be analyzed: narcosis, blinking with the eyes, involun­
tary muscular contractions (IVMC), grooming, vacuous chew­
ing with tongue protrusions, ear retraction, head and wet dog 
shakes, cyanosis, excitation (escape efforts, wild gross move­
ments), apnea, tail flicking (TF) and perturbed coordination. 
Apart from measuring the duration of narcosis in minutes 
(min), the incidence of all remaining items was scored and 
the incidence was expressed as percentage per injection.
Study on Withdrawal Reflex and Cardiovascular Variables
One week after the assessment of the behavioral effects, 
the rats were anesthetized with urethane. Determination of 
drug effects started 1 h after termination of the surgical prepa­
ration. In earlier studies, we had found that there are no 
significant fluctuations after that interval (13). The individual
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base-line of withdrawal force (F, expressed in g), intra-arterial 
(IA) pressures (mmHg) and heart rate (bpm) were then mea­
sured for 20 min. Consecutive IV injections of propofol 
through the jugular catheter formed the array of 0.75, 1.25, 
2.5,5,10 or 40 mg.kg"* of propofol, thereby including subanes­
thetic and anesthetic doses, and the midst of two stimuli (40 
s after an transcutaneous electrical stimulus) was the moment 
of injection. Consecutive injections were given once the force 
of the withdrawal responses was returned to pre-injection 
strength (see Figure 1: tension). For, the mentioned pilot study 
had shown that the propofol-induced change in the withdrawal 
reflex is the last symptom seen in rats which fully recover 
from propofol (13,14,15).
Data were sampled at 200 Hz (PC486-66Mhz; 8 Mb; fitted 
with a DAS-16 A/D board (Keithley Instr. Incorp. USA) with 
48,000 samples for each 80 s period (the stimulus interval). The 
measures for withdrawal reflex activity were: the magnitude of 
force of withdrawal (g) and indices for contraction [the b]/Peak 
(Aforce/At), with At = interval (min) between stimulus and 
maximum withdrawal], and for relaxation [the pcilk/ bI (Aforce/ 
At), with At = interval (min) between max. withdrawal and 
return to resting value]. The time course of reflex suppressive 
effect was assessed in terms of time constants ( t ;  min) of onset 
( t 0) and decay ( t j )  of the effect on the force of withdrawal. 
The measures for cardiovascular variables were: changes in 
heart rates (bpm) and changes in IA systolic (SAP) and dia­
stolic (DAP) pressures (mmHg). Variation of these variables 
was assessed within the stimulus interval:
‘HO
0.
IA variable^/1)
Figure la  shows both the cardiovascular response and the 
withdrawal reflex in a naive rat: it illustrates the indices used 
in data analysis. In Figure lb, the effect of 10 mg.kg-1 propofol 
in the same rat is shown to illustrate how the effects of propofol 
on these indices were analyzed.
STATISTICAL ANALYSIS
Statistical data handling was performed using SAS (SAS- 
PC v. 6.03, SAS Institute Inc., Cary NC). Two-tail probabilities 
were used in all tests; the level of statistical significance was 
set as p ^  0.05.
Study on Narcosis and Drug-Induced Behavior
The duration of narcosis was analyzed using ANOVA. Line 
differences in the incidence of IVMCs, vacuous chewing and 
grooming were assessed with the help of the Fisher exact test. 
Effect of dose was assessed with the help of k X 2 tables, with 
comparison of the effect among two doses assessed with 2 X 
2 tables.
Study on Withdrawal Reflex and Cardiovascular Variables
%
The effects were analyzed using ANOVA, with covariance 
analysis (indicated by DF (1)) or classes for dose. Where appro­
priate ANOVA was supplemented with Scheffes method for 
multiple comparisons. Data points are given as means and 
SEMs. Analysis of variables was performed on the values (in 
units of measurement) and on the change of these variables 
in terms of percentage of the mean of the individual base line 
before drug and the minimum response after injection of a 
dose of the drug.
The reflex suppressive effects were compared using the 
equation of the sigmoid Emax model (22,23). Fitting this equa-
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FIG. 1. Responses as a function of time of APO-SUS rat n° 2 a t two 
time scales (s and min), and the measures for effect are indicated: 
IA )  the responses of heart rate (H R), intra-arterial pressures (IAP; 
with SAP = systolic intra-arterial pressure; and, D A P  =  diastolic intra- 
arterial pressure), and reflex activities (withdrawal) of the urethane 
anesthetized rats to the s tandard  transcutaneous stimulus. This electri­
cal stimulus is given at 0 seconds. Max, bl, and min m ean the highest, 
the base line, and the lowest values of a variable in the 80 s period, 
respectively. The change of force (peak minus tension; g) and integrals 
for withdrawal (bl-peak) and relaxation (peak-bl) were calculated for 
each reflex. IB ) Pharmacological response of variables to 10 mg.kg-1 
of propofol. T he  injection is given at 0 min (arrow). The filled and 
open symbols represent the highest (max in Figure la )  and lowest 
(min in Figure IA ) values of H R , SAP, and D A P, respectively. The 
lower part of the figure shows the change of force of withdrawal (AF), 
with onset ( t u) and decay (T d)  of this response.
tion to the data yielded three parameter estimates: E max = 
maximum effect, -y = exponent (Hill coefficient; slope), and 
ED 50 =  dose causing 50% of the effect. Using these estimates, 
the kinetics of the pharmacological response were analyzed
D IR K SEN  E T  AL.
TABLE 1
THE INCIDENCE (%) AND DURATION (MIN) OF NARCOSIS 
IN RELATION TO THE DOSE (mg.kg-') OF PROPOFOL
APO-SUS APO-UNSUS
Dose Injection Incidence
Duration 
(mean ± SE) Incidence
Duration 
(mean ± SE)
4 first 0 0 22 0.7 ± 0.5
consecutive 88 5.7 ± 0.7 100 7.3 ± 0.4
10 first 77 7.8 ± 1.5 too 9.7 ± 0.7
consecutive 100 13.3 ±  0.3 100 11.9 ± 0.6
20 first L00 16.2 ±  0.9 100 17.7 ±  0.4
consecutive 100 18.0 ± 0.9 100 22.3 ± 1.3
A PO -SU S = apomorphine-susceptible rats; APO-UNSUS ~ apomorphine-unsuscepti- 
ble rats.
according to a one compartment open model (40). The mathe­
matical model included the full dose range and yielded the 
estimates of the time constants of onset and decay of effect 
of each individual rat.
RESULTS
Narcosis in APO-SUS and APO-UNSUS Rats
The incidence and duration of narcosis of APO-SUS and 
APO-UNSUS rats are given in Table 1, There was no signifi­
cant difference in the incidence of propofol-induced narcosis, 
not even when the effects of the first injections and the consec­
utive injections were separately analyzed.
The duration of narcosis depended on the dose of propofol 
and lasted longer after repeated injections, with no difference
for APO-SUS and APO-UNSUS rats as indicated by the out­
come of ANOVA with dose, repetition, line and body weight 
as factors [dose: F(2, 153) = 273,04, p <  0,0001; repetition: 
F(3,153) = 30.77, p <  0.0001; line: F{ 1,153) = 2.64,/? = 0.1; 
body weight: F(1, 153) = 1.70,/?= 0.2].
Propofol-induced Behavior in APO-SUS and 
APO-UNSUS Rats
Propofol resulted in a significant line-difference in involun­
tary muscular contractions (IVMCs), vacuous chewing with 
tongue protrusion and grooming (Figure 2).
The difference for the incidence of IVMCs in the two lines 
was remarkable (p <  0.0001) and the incidence related to the 
dose [x2 (17.5), p  <  0.0001]. When treated with 10 or 20 
mg.kg^1 propofol: APO-SUS rats had an incidence of 90- 
100% IVMCs, whereas APO-UNSUS rats had only an inci­
dence of 30-40% IVMCs (4 mg.kg“1 different from 10 and 
20 mg.kg“1: p -  0.004 and 0.001, respectively). The incidence 
of IVMCs was similar for first and consecutive injections 
(p = 1.0),
Vacuous chewing with tongue protrusion had a significantly 
higher incidence in APO-SUS than in the APO-UNSUS rats 
(p = 0.037); the incidence related to the dose [x2 (28.29), p < 
0.001; post hoc: 4 mg.kg“ 1 different from 10 and 20 m g.kg '1; 
p  <  0.001 and <  0.001, respectively]. No difference was found 
for the incidence of this behavior after first or consecutive 
injections (p  = 0.7).
The incidence of grooming was lower in the APO-SUS 
than in the APO-UNSUS rats (24% versus 39%, p = 0.01), 
and the difference was especially evident after the consecutive 
injections (incidence after first versus consecutive injections:
7% and 46%, respectively; p <  0.00i). There was no relation­
ship of effect and dose [xl (3.8), p  = 0.1].
There was no significant line-specific difference in the inci­
dence of eye lashing (54% and 63%), ear retraction (25% and 
3.1%), wet dog shake (20% and 15%), cyanosis (12% and 
21%), excitation (12% and 9%), apnea (6% and 7%), tail 
flick (5% and i% ), or disturbance of coordination (4% and 
0%). However, this study used a limited number of rats and 
additional differences may prove to be present when a larger 
population of rats is subjected to testing.
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FIG. 2. Incidences (% ) of propofol-induced behavior that differed 
for APO-SUS and APO-UNSUS rats, and the bars represent: £3: 
involuntary muscular contractions, 6Ë: vacuous chewing with tongue 
protrusion, grooming.
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FIG. 3. The magnitude of the withdrawal response (mean; gram) in 
relationship to the dose of propofol (mg.kg-1) (□: open = APO-SUS 
rats; filled = APO-UNSUS rats; the bars represent the SEM).
Prop o f  o f  Induced Changes in Withdrawal Reflex o f  
APO-SUS and APO-UNSUS Rats
The pre-drug values of withdrawal reflexes did not differ 
between the two lines of rats. Propofol reduced the force of 
withdrawal response in a dose-dependent fashion, and this 
effect did not differ between the two lines of rats [two-way
ANOVA, dose: F{ 1,115) = 32.31, p <  0.0001; line F[ 1,115) = 
0.3, p -  0.6; Fig. 3].
Likewise, the percentage change of contraction was not 
different between the two lines [dose: F( 1,115) = 41.33, p < 
0.0001; line F( 1, 115) = 0.00, p = 0.96]. Table 2 lists the 
means of the parameter estimates and standard errors of the 
estimates for y  and ED 5» after fitting the equation to the data 
on the change of withdrawal in terms of percentage for each 
individual rat (marked differences were found for parameter 
estimates in the asymptotic correlation matrices); Enli1x max­
imized at 100%.
Although there was a slight but significant difference of 
the Ttoy of the pharmacological response between APO-SUS 
rats and APO-UNSUS rats (Table 2; Figure 1), there was no 
significant effect of line and body weight.
The duration of actual contraction and that of subsequent 
relaxation of the hind limb were diminished in a dose-depen­
dent fashion, and these effects, or the change in terms of 
percentage did not differ between APO-SUS and APO- 
UNSUS rats (data not shown). After the return of the force 
of withdrawal to pre-propofol levels, peaiJbl (Aforce/At) was 
enhanced in a dose related fashion, F( 1, 115) = 5.46, p  = 
0.0001, and this effect was not different between the two lines.
Cardiovascular Variables: Heart Rate and 
Intra-Arterial Pressures
The base-line levels of the heart rates did not differ between 
the two lines of rats under urethane anesthesia, but the varia­
tion of the heart rate (0JS()H R) was significantly less for APO- 
SUS rats (230 ±  55 bpm.80 s "1) than for APO-UNSUS rats 
[480 ± 58 bpm.80 s~l: F(l, 15) = 9.19, p  <  0.01], due to the 
(twice as) long duration of the heart rate response to the 
electrical stimulus. This stimulus resulted in the significantly 
higher intra-arterial systolic pressures (SAP) in APO-SUS rats 
(154 ± 5 mmHg) than in APO-UNSUS rats [135 ± 5 mmHg: 
/ ’(l, 15) =  7.06, p  = 0.018]. Otherwise pre-propofol data did 
not differ between the two lines.
Propofol induced biphasic changes in heart rates and in 
IA pressures: a decrease followed by an increase of heart rate, 
systolic IA pressure and diastolic IA pressure. Variables for 
which significant changes between the two lines were found 
are shown in Figure 4; Table 3 provides an overview. The 
magnitude of the reductions in the heart rate differed between 
the two lines at the doses [dose: F(6y 105) = 29.96, p <  0.0001; 
line and dose: / '( l ,  6, 105) = 5.06, p  = 0.0001], The dose 
related increase of the heart rates differed between the two 
lines [dose: F(6, 105) =  5.83, p <  0.0001; line: F( 1, 105) = 
6.45» p = 0.013]. The variations (0 “°) of the heart rate were
reduced in a dose-dependent fashion, and to lesser extent in 
the APO-SUS rats [two-way ANOVA: dose: F (6 ,105) =  31.26, 
p  <  0.0001; line: F( 1, 105) = 17.1, p  = 0.0001].
Similar differences were found for the % change of the 
variables. The reduction in intra-arterial diastolic (DAP) and 
systolic pressures (SAP) was related to the dose. APO-SUS 
rats maintained higher i.a. pressures [two-way ANOVA: SAP: 
dose: F(l, 115) -  215.6, p  <  0.0001; line: F{1, 115) -  23.77, 
p  <  0.0001; DAP: dose: F( 1, 115) = 67.8, p  <  0.0001; line: 
F(1,115) =  23.23, p  <  0.0001], The %change of the SAP was 
dose dependent as well, F(1, 115) =  392.52, p <  0.0001, and 
the % reduction was less in APO-SUS rats, dose: /*(1, 115) = 
7.58, p = 0.007. The % reduction of the DAP was dose depen­
dent, F( 1, 115) = 88.15, p  <  0.0001, and was not different 
between the two lines, F (l, 115) = 2.18,/? = 0.13. The augmen­
tations of the IA pressures that followed initial reductions 
related to the dose and differed for the lines [SAP: dose: F(6, 
105) = 21.49, p <  0.0001, line: F(1, 105) = 9.03, p <  0.0001; 
DAP: dose: F(6, 105) =  14.95, p < 0.0001, line: F(l, 105) = 
34.78,/? <  0.0001]. Stimulus-related variations of IA pressures
TABLE 2
PARAMETER ESTIMATES AND SEM AFTER FITTING 
THE PHARMACODYNAMIC MODEL TO THE DATA OF 
THE REFLEX SUPPRESSIVE EFFECTS IN EACH INDIVIDUAL 
RAT AFTER CONSECUTIVE INJECTIONS OF PROPOFOL
Line 7 ED™ (mg.kg ') Ton set (rain) Tdccay (min)
SUS
UNSUS
2.22
1.87
±  0.22 
± 0.201
1.07 ±  0.14
1.07 ± 0.14
0.60 ±  0.09 
0.50 ±  0.06
12.7 ±  0.48 
10.4 ±  0.79
SUS = APO-SUS rats; UNSUS = APO-UNSUS rats.
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FIG* 4. Cardiovascular variables for APO-SUS (open symbols) and 
APO-UNSUS rats (filled symbols) in relationship to  the dose of propo­
fol (mg.kg"1). Symbols represent the m ean, bars the SEM  (an overview 
of the changes is given in Table 3). H R  =  heart rate (bpm =  beats 
per min); with reduction (★) and increase (O) of the heart rale; and 
change of variation of the heart rate  (O). Intra-arterial pressures 
(mmHg), with increases (O) and decreases (V) of the systolic IA 
pressure (SAP) and increases (O) and decreases (A) of the diastolic 
IA  pressure (DAP); and change of the variation o f  the D A P (□).
were dose-dependently reduced and to a greater extent in the 
APO-SUS rats [{,f°SAP: dose: F(6> 105) -  11.96, p  <  0.0001; 
line: F (l, 105) =  7.56, p =  0.007; J mDAF: dose: F (6 ,105) = 
16.78, p  <  0.0001; line: F(U 105) = 8,05, p -  0.005; Figure 4]. 
The % change in relation, to the dose did not differ between 
the two lines for the 0J 8()SAP [dose: F (l, 115) = 27.11, p  < 
0.0001; line: F{ 1, 115) = 0.05, p  = 0.8]; whereas 0JH0DAP 
differed for dose and line [dose: F(l,115) = 45.12, p <  0.0001; 
line jF(l, 115) -  10.82, p  -  0.0013],
General
In the present study it was investigated to what extent the 
effects of the anesthetic propofol that is known to enhance 
indirectly the G ABA transmission, vary in rats that show geneti­
cally determined differences in the cerebral GAB A transmis­
sion, namely rats belonging to the APO-SUS and APO-UN­
SUS Wistar rat lines. The main findings of this study are: (1) 
propofol induces narcosis and suppression of the withdrawal 
reflexes of the hindlimb of APO-SUS and APO-UNSUS rats
equally in a dose-dependent manner; (2) propofol elicited a 
number of behavioral signs that differ between the two lines of 
rats; and (3) propofol alters certain cardiovascular parameters 
which also differed between the two types of rats. These find­
ings are discussed separately.
Narcosis and Withdrawal Reflexes
Narcosis was induced by propofol in APO-UNSUS and 
APO-SUS rats, and this effect required similar doses. Analo­
gous results were obtained in experiments assessing propofol- 
induced changes in withdrawal reflex. There were no signifi­
cant differences between the two lines as far as dose dependent 
suppression of the reflex activity was concerned.
The absence of any line-specific difference in sensitivity to 
propofol’s anesthetic effect may be explained in two ways: 
either the genetically determined differences in GAB A trans­
mission between APO-SUS and APO-UNSUS rats do not 
significantly extend to those brain structures that mediate the 
anesthetic effect of propofol, and/or the anesthetic effect of 
propofol is only mediated via its ability to enhance the G AB A- 
ergic transmission in the brain to a minor degree (1,9,21,32). 
In this context it is relevant to note that comparison of line- 
specific differences in the neostriatum, its first-order output 
station, namely the substantia nigra pars reticulata, and its 
second-order output station, namely the deeper layers of the 
colliculus superior, shows that these differences diminish in­
creasingly (10). In other words, the line-specific differences 
become smaller as the brain region in question is further away 
from the telencephalon and closer to the brainstem and spinal 
cord. This is consistent with our data on the absence of a 
line-specific difference in propofoi-induced reflex suppressive 
effects which are thought to be mainly mediated by structures 
in the brainstem and spinal cord.
Behavior
Propofol induced IVMCs in both lines, and the incidence 
of IVMCs was significantly higher in APO-SUS rats than in 
APO-UNSUS rats. The origin of this sign is not known. My­
oclonic jerks and muscle spasms can be induced by inhibiting 
the GABA transmission in the colliculus superior (Ellen- 
broek & Cools, unpublished data). Given the fact that there 
is an inverse relationship between the GABAergic transmis­
sion in the colliculus superior and the substantia nigra pars 
reticulata (5), this would imply that enhancing the GABA 
transmission in the substantia nigra pars reticulata might also 
induce myoclonic jerks. To our knowledge, this has so far not 
been studied. However, APO-SUS rats are characterized by 
a lower functional activity of GABA in the substantia nigra, 
pars reticulata (10) and, accordingly, are more sensitive to 
GABA than APO-UNSUS rats. This together with the known 
facilitating effect of propofol upon GABA transmission sug­
gests that the genetically determined differences in GABA
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FIG. 5, Model of defined differences in G A B A  functionality within 
structures of the brain of APO-SUS and APO-UNSUS rats and effects 
of propofol. The incidence of drug-induced behavior may be greater 
(>) or not different (= ).
activity in the substantia nigra, pars reticulata (Figure 5) might 
have contributed to the line-speciiic difference in propofol- 
induced IVMCs.
Propofol induced oral movements, and the incidence of 
this sign was significantly higher in the APO-SUS rats than 
in the APO-UNSUS rats: APO-SUS rats showed significantly 
more vacuous chewing with tongue protrusion than APO- 
UNSUS rats did. The neural mechanisms underlying this effect 
are virtually unknown. In general, oral movements are subdi­
vided into object oriented (like gnawing) and non-object ori­
ented (like vacuous chewing) mouth movements. Many studies 
have shown that the neuronal substrates for these two catego­
ries of oral movements are, at least partly, different. For in­
stance, stimulation of GABA transmission in the substantia 
nigra, pars reticulata leads to object oriented gnawing (35), 
whereas inhibition of GABA transmission in the same struc­
ture leads to non-object oriented vacuous chewing movements 
(20). The oral movements observed in this study were non­
object oriented. However propofol had caused general anes­
thesia as well and, thus, prevented the animals from displaying 
object oriented behavior. Taking this into account, it is possi­
ble that the genetically determined differences in GABA activ­
ity in the substantia nigra, pars reticulata might have contrib­
uted to the line-specific difference in propofol-induced oral 
movements (10).
Propofol induced grooming which mainly consisted of face 
washing. This study shows that APO-SUS rats showed signifi­
cantly less propofol-induced grooming than APO-UNSUS rats 
did. In awake unmedicated rats, this type of grooming is con­
sidered to be a displacement activity (36) and occurs when an 
animal is challenged by novelty (16), Grooming also occurs 
when the animal is falling asleep (2). These features may be 
brought about by the anesthetic: the novelty of literally falling 
asleep (narcosis). It is known that stimulation of GABA trans­
mission in the colliculus superior enhances ACTH- and swim­
ming-induced grooming (37; Ellenbroek & Cools unpublished 
data). APO-SUS rats are characterized by a higher functional 
activity of GABA in the colliculus superior (10) and are, 
accordingly, less sensitive to GABA than APO-UNSUS rats 
at this level of the brain. This together with the fact that 
propofol enhances GABA transmission (1,9,21,32) suggests 
that genetically determined difference in GABA transmission 
at the level of the deeper layers of the colliculus superior might 
have contributed to the line-specific difference in propofol- 
induced grooming.
Cardiovascular Responses
APO-SUS rats had a lower baseline level of stimulus- 
induced heart rate variability as well as a greater variation in 
the diastolic IA pressure than APO-UNSUS rats. The dose- 
related reduction of cardiovascular variables reduced the line- 
specific differences in level and stimulation-evoked variations 
of the cardiovascular variables, whereas the opposite occurred
TABLE 3
A COMPARISON OF THE CARDIOVASCULAR VARIABLES 
IN APO-SUS AND APO-UNSUS RATS BEFORE INJECTIONS OF 
PROPOFOL AND THE DIFFERENCES IN THE DOSE-DEPENDENT
REDUCTIONS OF THESE VARIABLES AFTER
INJECTIONS OF PROPOFOL
Variable
Propofol-induced Reduction
Base Line Actual Change % Change
H R  level
variability 
SAP level
variability 
D A P level
variability
SUS =  UNSUS 
SUS <  UNSUS 
SUS >  UNSUS 
SUS = UNSUS 
SUS = UNSUS 
SUS >  UNSUS
SUS <  UNSUS 
SUS <  UNSUS 
SUS >  UNSUS 
SUS >  UNSUS 
SUS >  UNSUS 
SUS >  UNSUS
SUS
SUS
sus
sus
sus
sus
<  U N SU S
<  UNSUS
>  UNSUS 
=  U N SU S 
=  U N SU S
>  UNSUS
SUS =  APO-SUS rats; UNSUS =  APO-UNSUS rats; =  not different; 
larger than (p  <  0.05); <  less than (p  < 0.05),
The actual changes in relationship to the dose are shown in Fig. 4.
>
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during the vanishing of the effect. In fact, propofol-treated 
APO-SUS rats displayed a greater cardiovascular respon­
siveness with higher rebound heart rates and intra-arterial 
pressures than APO-UNSUS rats. Apart from the fact that 
APO-SUS are known to be far more sensitive to stressor- 
induced behavioral responses than APO-UNSUS rats (10), 
APO-SUS rats also have lower plasma levels of free corticoste­
roids during rest conditions and have a greater release of 
ACTH, corticosteroids and noradrenaline and a lower release 
of adrenaline in response to mild stressors compared to APO- 
UNSUS rats (33; Rots et al., personal communications). The 
noted line-specific baseline differences in cardiovascular pa­
rameters as well as the line-specific differences in response 
to propofol fully fit in with these line-specific differences in 
sensitivity to stressors. Finally, genetically determined differ­
ences in the GABA transmission at supraspinal level have 
been found to be associated with differences in cardiovascular 
responses (17). To what extent the known line-specific differ­
ence in the GABA-ergic make-up of the forebrain has also 
contributed to the noted line-specific differences in cardiovas­
cular responses remains to be investigated.
CONCLUSION
The present study shows that genetically determined differ­
ences in cerebral G A B A  transmission, especially in the striato- 
nigro-collicular pathway, do not give rise to differences in the 
effect of the anesthetic propofol upon narcosis and suppres­
sion of the hindlimb withdrawal reflex. Since the rats under 
study are marked by other genetically determined differences
in the make-up of the brain (10,11,12) which may theoretically 
mask the role of the GABA-ergic striato-nigro-collicular path­
way, we cannot exclude a role for this pathway in these effects. 
This study suggests that genetically determined differences in 
the GABA-ergic striato-nigro-collicular pathway give rise to 
differences in the effect of propofol upon certain cardiovascu­
lar and behavioral parameters, although it cannot yet be ex­
cluded that additional, genetically determined differences may 
be involved as well.
The genetically determined difference in the GABA trans­
mission between APO-SUS and APO-UNSUS rats is only 
one of many features that are characteristic for these animals 
(11,12). They are no mutants, but occur normally in every 
unselected outbred strain of Wistar rats. Each type has its 
own individual-specific hardware and software to cope with 
the challenges from the internal and external environment, 
and has its own vulnerability to therapeutic and unwanted 
side-effects of centrally acting drugs (11). The present study 
extends these data by showing that the greater vulnerability 
of APO-SUS rats for propofol-induced IVMCs and vacuous 
chewing co-exist with particular baseline features of the car­
diovascular system. In other words, these cardiovascular fea­
tures which co-exist with particular behavioral features (12), 
may represent biological features that can be used to predict 
to what extent rats will display these side-effects in response 
to propofol. Extrapolating the present findings to man and 
other anesthetics results in the notion that both cardiovascular 
and behavioral/psychological characteristics may be useful for 
predicting to what extent anesthetics can elicit unwanted side- 
effects in the individual patient.
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